Amylyx Pharmaceuticals, Inc. (AMLX) Operating income 2021–2025
Amylyx Pharmaceuticals, Inc. (AMLX) annual operating income history from SEC filings — each fiscal year as reported.
-$153.3MFY2025 · since FY2021: -$82.7M → -$153.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$153.3M | +51.3% |
| FY2024 | -$314.7M | -911.1% |
| FY2023 | $38.8M | +119.3% |
| FY2022 | -$201.3M | -143.5% |
| FY2021 | -$82.7M | — |
Source: SEC XBRL filings · For reference only · Not investment advice